EGFR and neoplasm: (b) AEE788 is a dual EGFR and VEGFR Tyrosine Kinase Inhibitor (TKI) studied both in vitro and in vivo for its anti-tumor effect, alone or in combination with chemotherapy (cisplatin or paclitaxel) [57].